AUTL
Price
$1.78
Change
-$0.07 (-3.78%)
Updated
Aug 15 closing price
Capitalization
473.73M
73 days until earnings call
LRMR
Price
$4.01
Change
-$0.25 (-5.87%)
Updated
Aug 15 closing price
Capitalization
343.22M
92 days until earnings call
Interact to see
Advertisement

AUTL vs LRMR

Header iconAUTL vs LRMR Comparison
Open Charts AUTL vs LRMRBanner chart's image
Autolus Therapeutics
Price$1.78
Change-$0.07 (-3.78%)
Volume$12.16M
Capitalization473.73M
Larimar Therapeutics
Price$4.01
Change-$0.25 (-5.87%)
Volume$1.88M
Capitalization343.22M
AUTL vs LRMR Comparison Chart in %
Loading...
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AUTL vs. LRMR commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AUTL is a Hold and LRMR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 18, 2025
Stock price -- (AUTL: $1.78 vs. LRMR: $4.26)
Brand notoriety: AUTL and LRMR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AUTL: 589% vs. LRMR: 1%
Market capitalization -- AUTL: $473.73M vs. LRMR: $343.22M
AUTL [@Biotechnology] is valued at $473.73M. LRMR’s [@Biotechnology] market capitalization is $343.22M. The market cap for tickers in the [@Biotechnology] industry ranges from $100.71B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AUTL’s FA Score shows that 1 FA rating(s) are green whileLRMR’s FA Score has 1 green FA rating(s).

  • AUTL’s FA Score: 1 green, 4 red.
  • LRMR’s FA Score: 1 green, 4 red.
According to our system of comparison, LRMR is a better buy in the long-term than AUTL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AUTL’s TA Score shows that 6 TA indicator(s) are bullish while LRMR’s TA Score has 4 bullish TA indicator(s).

  • AUTL’s TA Score: 6 bullish, 5 bearish.
  • LRMR’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AUTL is a better buy in the short-term than LRMR.

Price Growth

AUTL (@Biotechnology) experienced а -23.61% price change this week, while LRMR (@Biotechnology) price change was +18.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.94%. For the same industry, the average monthly price growth was +21.39%, and the average quarterly price growth was +21.23%.

Reported Earning Dates

AUTL is expected to report earnings on Oct 30, 2025.

LRMR is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+5.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AUTL($474M) has a higher market cap than LRMR($343M). LRMR YTD gains are higher at: 10.078 vs. AUTL (-24.255). LRMR has higher annual earnings (EBITDA): -105.02M vs. AUTL (-226.02M). AUTL has more cash in the bank: 517M vs. LRMR (158M). LRMR has less debt than AUTL: LRMR (4.87M) vs AUTL (57.7M). AUTL has higher revenues than LRMR: AUTL (9.01M) vs LRMR (0).
AUTLLRMRAUTL / LRMR
Capitalization474M343M138%
EBITDA-226.02M-105.02M215%
Gain YTD-24.25510.078-241%
P/E RatioN/AN/A-
Revenue9.01M0-
Total Cash517M158M327%
Total Debt57.7M4.87M1,186%
FUNDAMENTALS RATINGS
AUTL vs LRMR: Fundamental Ratings
AUTL
LRMR
OUTLOOK RATING
1..100
5080
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
31
Undervalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
97100
PRICE GROWTH RATING
1..100
6438
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
8536

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AUTL's Valuation (22) in the Biotechnology industry is in the same range as LRMR (31) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

AUTL's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

AUTL's SMR Rating (97) in the Biotechnology industry is in the same range as LRMR (100) in the null industry. This means that AUTL’s stock grew similarly to LRMR’s over the last 12 months.

LRMR's Price Growth Rating (38) in the null industry is in the same range as AUTL (64) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AUTL’s over the last 12 months.

LRMR's P/E Growth Rating (100) in the null industry is in the same range as AUTL (100) in the Biotechnology industry. This means that LRMR’s stock grew similarly to AUTL’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AUTLLRMR
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bearish Trend 4 days ago
85%
Bullish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
86%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
88%
Bullish Trend 4 days ago
84%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
87%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 27 days ago
82%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
88%
Bearish Trend 11 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
84%
Aroon
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 4 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
AUTL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LRMR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HTHIY29.100.29
+1.01%
Hitachi Ltd.
EMYB15.93N/A
N/A
Embassy Bancorp Inc.
NLTBF6.48N/A
N/A
Nolato AB
CAIB0.08N/A
N/A
California International Bank
JBHIF74.00N/A
N/A
JB Hi-Fi Limited

AUTL and

Correlation & Price change

A.I.dvisor indicates that over the last year, AUTL has been loosely correlated with OCUL. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if AUTL jumps, then OCUL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AUTL
1D Price
Change %
AUTL100%
-3.78%
OCUL - AUTL
48%
Loosely correlated
-0.24%
SCPH - AUTL
46%
Loosely correlated
-7.07%
CRSP - AUTL
45%
Loosely correlated
+1.55%
LRMR - AUTL
44%
Loosely correlated
N/A
IMCR - AUTL
43%
Loosely correlated
-0.54%
More

LRMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, LRMR has been loosely correlated with ERAS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if LRMR jumps, then ERAS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LRMR
1D Price
Change %
LRMR100%
N/A
ERAS - LRMR
49%
Loosely correlated
+4.46%
OCUL - LRMR
48%
Loosely correlated
-0.24%
SYRE - LRMR
48%
Loosely correlated
+0.53%
EYPT - LRMR
48%
Loosely correlated
+2.21%
ACLX - LRMR
47%
Loosely correlated
+3.09%
More